Skip to main content
SpringerLink
Log in
Book cover

N-Acetylaspartate pp 241–262Cite as

N-Acetylaspartate as a Marker of Neuronal Injury in Neurodegenerative Disease

  • Conference paper

Part of the book series: Advances in Experimental Medicine and Biology ((volume 576))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   229.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

14. References

  1. Chui HC. Dementia due to subcortical ischemic vascular disease. Clin Cornerstone 2001;3(4):40–51.

    Article  PubMed  CAS  Google Scholar 

  2. Fein G, Di S, V, Tanabe J, et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease [In Process Citation]. Neurology 2000;55(11):1626–35.

    PubMed  CAS  Google Scholar 

  3. Mungas D, Jagust WJ, Reed BR, et al. MRI Predictors of Cognition in Subcortical Ischemic Vascular Disease and Alzheimer’s Disease. Neurology 2001;57(12):2229–35.

    PubMed  CAS  Google Scholar 

  4. Du AT, Schuff N, Laakso MP, et al. Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus. Neurology 2002;58(11):1635–41.

    PubMed  CAS  Google Scholar 

  5. Laakso MP, Partanen K, Riekkinen P, et al. Hippocampal volumes in Alzheimer’s disease, Parkinson’s disease with and without dementia, and in vascular dementia: An MRI study. Neurology 1996;46:678–81.

    PubMed  CAS  Google Scholar 

  6. Baron JC, D’Antona R, Pantano P, Serdaru M, Samson Y, Bousser MG. Effects of thalamic stroke on energy metabolism of the cerebral cortex. A positron tomography study in man. Brain 1986;109 (Pt 6):1243–59.

    PubMed  Google Scholar 

  7. Kwan LT, Reed BR, Eberling JL, et al. Effects of subcortical cerebral infarction on cortical glucose metabolism and cognitive function. ArchNeurology 1999;56:809–14.

    CAS  Google Scholar 

  8. Rango M, Spagnoli D, Tomei G, Bamonti F, Scarlato G, Zetta L. Central Nervous System Trans-Synaptic Effects of Acute Axonal Injury: A 1H Magnetic Resonance Spectroscopy Study. MRM ed: Williams & Wilkins; 1995.

    Google Scholar 

  9. Escobar A. Cerebral changes associated with senility. I. The role of transneuronal degeneration in the neocortex. Bol Estud Med Biol 1973;28(1):1–8.

    PubMed  CAS  Google Scholar 

  10. Schuff N, Capizzano AA, Du AT, et al. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD. Neurology 2002;58(6):928–35.

    PubMed  CAS  Google Scholar 

  11. Southwick SM, Paige S, Morgan CA, Bremner JD, Krystal JH, Charney DS. Neurotransmitter alterations in PTSD: catecholamines and serotonin. Semin Clin Neuropsychiatry 1999;4(4):242–8.

    PubMed  CAS  Google Scholar 

  12. Wang S, Mason J, Southwick S, Johnson D, Lubin H, Charney D. Relationships between thyroid hormones and symptoms in combat-related posttraumatic stress disorder. Psychosom Med 1995;57(4):398–402.

    PubMed  CAS  Google Scholar 

  13. Yehuda R, Southwick SM, Krystal JH, Bremner D, Charney DS, Mason JW. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. AmJPsychiatry 1993;150(1):83–6.

    CAS  Google Scholar 

  14. Bremner JD, Randall P, Scott TM, et al. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry 1995;152:973–81.

    PubMed  CAS  Google Scholar 

  15. Gurvits TV, Shenton ME, Hokama H, et al. Magnetic resonance imaging study of hippocampal volume in chronic, combat-related post-traumatic stress disorder. Biological Psychiatry 1996;40:1091–9.

    Article  PubMed  CAS  Google Scholar 

  16. Bremner JD, Randall P, Vermetten E, et al. MRI-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse-A preliminary report. Biological Psychiatry 1997;41:23–32.

    Article  PubMed  CAS  Google Scholar 

  17. Stein MB, Koverola C, Hanna C, Torchia MG, McClarty B. Hippocampal volume in women victimized by childhood sexual abuse. Psychol Med 1997;27(4):951–9.

    Article  PubMed  CAS  Google Scholar 

  18. Schuff N, Marmar CR, Weiss DS, et al. Reduced hippocampal volume and nacetylaspartate in post traumatic stress disorder. The Annals of the New York Academy of Sciences 1997; Supplement on Psychobiology of Posttraumatic Stress Disorder(821):516–20.

    Google Scholar 

  19. Freeman TW, Cardwell D, Karson CN, Komoroski RA. In vivo proton magnetic resonance spectroscopy of the medial temporal lobes of subjects with combat-related posttraumatic stress disorder. MagnResonMed 1998;40(1):66–71.

    CAS  Google Scholar 

  20. Schuff N, Amend D, Ezekiel F, et al. Changes of hippocampal n-acetylaspartate and volume in Alzheimer’s disease: A proton MR spectroscopic imaging and MRI study. Neurology 1997;49:1513–21.

    PubMed  CAS  Google Scholar 

  21. Kalra S, Cashman NR, Genge A, Arnold DL. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport 1998;9(8):1757–61.

    PubMed  CAS  Google Scholar 

  22. Hugg JW, Kuzniecky RI, Gilliam FG, Morawetz RB, Faught RE, Hetherington HP. Normalization of contralateral metabolic function following temporal lobectomy demonstrated by h-1 magnetic resonance spectroscopic imaging. Ann Neurol 1996;V40:236–9.

    Article  Google Scholar 

  23. De Stefano N, Matthews PM, Arnold DL. Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995;34:721–7.

    PubMed  Google Scholar 

  24. Bertolino A, Callicott JH, Mattay VS, et al. The effect of treatment with antipsychiatric drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biological Psychiatry 2001;49:39–46.

    Article  PubMed  CAS  Google Scholar 

  25. Heimberg C, Komoroski RA, Lawson WB, Cardwell D, Karson CN. Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect. Psychiatry Res 1998;83(2):105–15.

    PubMed  CAS  Google Scholar 

  26. Meyerhoff DJ, Weiner MW, Fein G. Deep gray matter structures in HIV infection: a proton MR spectroscopic study. AJNR Am J Neuroradiol 1996;17(5):973–8.

    PubMed  CAS  Google Scholar 

  27. Meyerhoff DJ, Cardenas V, Studholme C, et al. Evidence for Brain Damage in Treated HIV-Infected Individuals. Neurology 2003;60(5):A186.

    Google Scholar 

  28. Meyerhoff DJ, Truran D, Flenniken D, Song E, Studholme C, Weiner MW. Longitudinal Multi-Slice Short-Te 1H MRSI Reveals On Going Brain Metabolite Injury In Treated HIV+ Patients And In Chronic Heavy Drinkers. Proc Intl Soc Mag Reson Med 2004;11:290.

    Google Scholar 

  29. Fein G, Meyerhoff DJ, Di Sclafani V, et al. 1H magnetic resonance spectroscopic 1994:227–41.

    Google Scholar 

  30. O’Neill J, Cardenas VA, Meyerhoff DJ. Separate and interactive effects of cocaine and alcohol dependence on brain structures and metabolites: quantitative MRI and proton MR spectroscopic imaging. Addiction Biology 2001;6:347–61.

    Article  PubMed  CAS  Google Scholar 

  31. O’Neill J, Cardenas VA, Meyerhoff DJ. Effects of abstinence on the brain: quantitative magnetic resonance imaging and magnetic resonance spectroscopic imaging in chronic alcohol abuse. Alcohol Clin Exp Res 2001;25(11):1673–82.

    Article  PubMed  CAS  Google Scholar 

  32. Gazdzinski S, Durazzo TC, Meyerhoff D. Brain Recovery During Abstinence from Alcohol: MRI, MR Spectroscopic Imaging, and Neurocognitive Studies. In: American Academy of Neurology 56th Annual Meeting; 2004; Moscone Convention Center, San Francisco, CA USA: American Academy of Neurology; 2004. p. A542.

    Google Scholar 

  33. Meyerhoff D, Blumenfeld R, Truran D, et al. Effects of heavy drinking, binge drinking, and family history of alcoholism on regional brain metabolites. Alcohol Clin Exp Res 2004;28(4):650–61.

    PubMed  CAS  Google Scholar 

  34. Bloomer CW, Langleben DD, Meyerhoff DJ. Magnetic resonance detects brainstem changes in chronic, active heavy drinkers. Psychiatry Res 2004; 132(3): 209–18

    PubMed  Google Scholar 

  35. Duc O, Trabesinger AH, Weber OM, et al. Quanititative 1HMRS in the evaluation of mesial temporal lobe epilepsy in vivo. Magn Reson Imaging 1998;16:969–79.

    Article  PubMed  CAS  Google Scholar 

  36. Suhy J, Laxer KD, Capizzano AA, et al. 1H MRSI predicts surgical outcome in MRI-negative temporal lobe epilepsy. Neurology 2002;58(5):821–3.

    PubMed  CAS  Google Scholar 

  37. Mueller S, Laxer K, Barakos J, et al. Focus identification in neocortical epilepsy with MR-spectroscopic imaging. Submitted.

    Google Scholar 

  38. Mueller S, Laxer K, Barakos J, et al. Metabolic characteristics causing epilepsy. Submitted.

    Google Scholar 

  39. Ende GR, Laxer KD, Knowlton RC, et al. Temporal lobe epilepsy: bilateral hippocampal metabolite changes revealed at proton MR spectroscopic imaging. Radiology 1997;202(3):809–17.

    PubMed  CAS  Google Scholar 

  40. Cendes F, Andermann F, Dubeau F, Matthews PM, Arnold DL. Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy-Evidence from proton MR spectroscopic imaging. Neurology 1997;49:1525–33.

    PubMed  CAS  Google Scholar 

  41. Mueller S, Laxer K, Cashdollar N, Flenniken D, Matson G, Weiner M. Identification of Abnormal Neuronal Metabolism Outside the Seizure Focus in Temporal Lobe Epilepsy. Epilepsia 2004;45(4):355–66.

    Article  PubMed  Google Scholar 

  42. Mueller S, Suhy J, Laxer K, et al. Reduced extrahippocampal NAA in mesial temporal lobe epilepsy. Epilepsia 2002;43:1210–6.

    Article  PubMed  Google Scholar 

  43. Pioro EP, Antel JP, Cashman NR, Arnold DL. Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology 1994;44(10):1933–8.

    PubMed  CAS  Google Scholar 

  44. Jones AP, Gunawardena WJ, Coutinho CM, Gatt JA, Shaw IC, Mitchell JD. Preliminary results of proton magnetic resonance spectroscopy in motor neurone disease (amytrophic lateral sclerosis). J Neurol Sci 1995;129Suppl:85–9.

    Article  PubMed  Google Scholar 

  45. Gredal O, Rosenbaum S, Topp S, Karlsborg M, Strange P, Werdelin L. Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy [see comments]. Brain 1997;48(4):878–81.

    CAS  Google Scholar 

  46. Giroud M, Walker P, Bernard D, et al. Reduced brain N-acetyl-aspartate in frontal lobes suggests neuronal loss in patients with amyotrophic lateral sclerosis [published erratum appears in Neurol Res 1997 Aug;19(4):456]. NeurolRes 1996;18(3):241–3.

    CAS  Google Scholar 

  47. Cwik VA, Hanstock CC, Allen PS, Martin WR. Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy. Neurology 1998;50(1):72–7.

    PubMed  CAS  Google Scholar 

  48. Ellis CM, Simmons A, Andrews C, Dawson JM, Williams SC, Leigh PN. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings. Neurology 1998;51(4):1104–9.

    PubMed  CAS  Google Scholar 

  49. Block W, Karitzky J, Treaber F, et al. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements [see comments]. Arch Neurol 1998;55(7):931–6.

    Article  PubMed  CAS  Google Scholar 

  50. Pioro EP, Majors AW, Mitsumoto H, Nelson DR, Ng TC. 1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla. Neurology 1999;53(1):71–9.

    PubMed  CAS  Google Scholar 

  51. Bradley WG, Bowen BC, Pattany PM, Rotta F. 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. J Neurol Sci 1999;169(1–2):84–6.

    Article  PubMed  CAS  Google Scholar 

  52. Bowen BC, Pattany PM, Bradley WG, et al. MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. Am J Neuroradiol 2000;21(4):647–58.

    PubMed  CAS  Google Scholar 

  53. Chan S, Shungu DC, Douglas-Akinwande A, Lange DJ, Rowland LP. Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain. 1999;212(3):763–9.

    CAS  Google Scholar 

  54. Tarducci R, Sarchielli P, Presciutti O, et al. Study of the primary motor cortex in amyotrophic lateral sclerosis by quantitative 1HMRS. ISMRM 2000;1:632.

    Google Scholar 

  55. Petropoulos H, Mandler RN, Qualls C, et al. 1H-MRS reveals diffuse neuronal injury in Amyotrophic Lateral Sclerosis. ISMRM 2000;1:633.

    Google Scholar 

  56. Kalra S, Arnold DL, Cashman NR. Biological markers in the diagnosis and treatment of ALS. J Neurol Sci 1999;165Suppl 1:S27–S32.

    Article  PubMed  CAS  Google Scholar 

  57. Rooney WD, Miller RG, Gelinas D, Schuff N, Maudsley AA, Weiner MW. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Neurology 1998;50(6):1800–5.

    PubMed  CAS  Google Scholar 

  58. Schuff N, Rooney WD, Miller RG, et al. Reanalysis of Multislice 1H MRSI in Amyotrophic Lateral Sclerosis. Magnetic Resonanc in Medicine 2001;45:513–6.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Magnetic Resonance Unit VA Medical Center, Department of Radiology, University of California, San Francisco, CA, 94121, USA

    Michael W. Weiner

Authors
  1. Norbert Schuff
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dieter J. Meyerhoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Susanne Mueller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Linda Chao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Diana Truran Sacrey
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kenneth Laxer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Michael W. Weiner
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA

    John R. Moffett  & Aryan M. A. Namboodiri  & 

  2. University of Albany, Albany, NY, 12222, USA

    Suzannah B. Tieman

  3. National Institute of Mental Health, Bethesda, MD, 20814, USA

    Daniel R. Weinberger

  4. McLean Hospital, Belmont, MA, 02178, USA

    Joseph T. Coyle

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, Inc.

About this paper

Cite this paper

Schuff, N. et al. (2006). N-Acetylaspartate as a Marker of Neuronal Injury in Neurodegenerative Disease. In: Moffett, J.R., Tieman, S.B., Weinberger, D.R., Coyle, J.T., Namboodiri, A.M.A. (eds) N-Acetylaspartate. Advances in Experimental Medicine and Biology, vol 576. Springer, Boston, MA . https://doi.org/10.1007/0-387-30172-0_17

Download citation

Publish with us

Policies and ethics

Search

Navigation